BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 17145803)

  • 1. Aurora kinases: new targets for cancer therapy.
    Carvajal RD; Tse A; Schwartz GK
    Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora kinase inhibitors as anti-cancer therapy.
    Lok W; Klein RQ; Saif MW
    Anticancer Drugs; 2010 Apr; 21(4):339-50. PubMed ID: 20016367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a future for Aurora kinase inhibitors for anticancer therapy?
    Carpinelli P; Moll J
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and biological evaluation of a novel aurora A kinase inhibitor.
    Sardon T; Cottin T; Xu J; Giannis A; Vernos I
    Chembiochem; 2009 Feb; 10(3):464-78. PubMed ID: 19199284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora kinase inhibitors.
    Kitzen JJ; de Jonge MJ; Verweij J
    Crit Rev Oncol Hematol; 2010 Feb; 73(2):99-110. PubMed ID: 19369091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora kinases as targets for cancer therapy.
    Mountzios G; Terpos E; Dimopoulos MA
    Cancer Treat Rev; 2008 Apr; 34(2):175-82. PubMed ID: 18023292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora A: target invalidated?
    Cochran AG
    Chem Biol; 2008 Jun; 15(6):525-6. PubMed ID: 18559262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Aurora kinase inhibitor patents.
    Coumar MS; Cheung CH; Chang JY; Hsieh HP
    Expert Opin Ther Pat; 2009 Mar; 19(3):321-56. PubMed ID: 19441907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of Aurora kinase inhibitors in cancer.
    Naruganahalli KS; Lakshmanan M; Dastidar SG; Ray A
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1044-51. PubMed ID: 17209521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of aurora kinase inhibitors as anticancer agents.
    Pollard JR; Mortimore M
    J Med Chem; 2009 May; 52(9):2629-51. PubMed ID: 19320489
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with aurora kinase inhibitors: a review.
    Boss DS; Beijnen JH; Schellens JH
    Oncologist; 2009 Aug; 14(8):780-93. PubMed ID: 19684075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aurora A and B kinases as targets for cancer: will they be selective for tumors?
    Matthews N; Visintin C; Hartzoulakis B; Jarvis A; Selwood DL
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):109-20. PubMed ID: 16375648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic drivers--inhibitors of the Aurora B Kinase.
    Keen N; Taylor S
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):185-95. PubMed ID: 19189202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora kinases as anticancer drug targets.
    Gautschi O; Heighway J; Mack PC; Purnell PR; Lara PN; Gandara DR
    Clin Cancer Res; 2008 Mar; 14(6):1639-48. PubMed ID: 18347165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora kinase inhibitors: a new class of targeted drugs in cancer.
    Gautschi O; Mack PC; Davies AM; Lara PN; Gandara DR
    Clin Lung Cancer; 2006 Sep; 8(2):93-8. PubMed ID: 17026809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase.
    Yang H; Burke T; Dempsey J; Diaz B; Collins E; Toth J; Beckmann R; Ye X
    FEBS Lett; 2005 Jun; 579(16):3385-91. PubMed ID: 15922328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danusertib, an aurora kinase inhibitor.
    Meulenbeld HJ; Mathijssen RH; Verweij J; de Wit R; de Jonge MJ
    Expert Opin Investig Drugs; 2012 Mar; 21(3):383-93. PubMed ID: 22242557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule inhibition of Aurora kinases triggers spindle checkpoint-independent apoptosis in cancer cells.
    Sun L; Li D; Dong X; Yu H; Dong JT; Zhang C; Lu X; Zhou J
    Biochem Pharmacol; 2008 Mar; 75(5):1027-34. PubMed ID: 18163976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitors of aurora kinases].
    Pinel S; Barbault-Foucher S; Lott-Desroches MC; Astier A
    Ann Pharm Fr; 2009 Mar; 67(2):69-77. PubMed ID: 19298889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.